Building the Future of Psilocybin Policy in New Mexico
We’re proud to share that the Psychedelic Bar Association’s New Mexico Working Group recently submitted an official public comment to the New Mexico Department of
Want to do more for The Psychedelic Bar Association?
We’re proud to share that the Psychedelic Bar Association’s New Mexico Working Group recently submitted an official public comment to the New Mexico Department of
[DENVER, COLORADO] — In response to President Trump’s April 18, 2026 executive order (EO) on “Accelerating Medical Treatments for Serious Mental Illness,” the Psychedelic Bar
In response to executive orders targeting law firms and other challenges to the rule of law and due process, as well as statements by the
High-Threat Patents: The Consequences of Inadequate Prior Art Research When Attorneys Fail to Acknowledge Traditional Psychedelic Uses Written by D. Burgundy Morgan, J.D. with contributions
A Call to Reform Contract Language Using the Term “Master” Written by D. Burgundy Morgan, J.D., Special Acknowledgment to Roman Haferd, J.D., Ethics Committee Board
The FDA’s rejection of Lykos’ NDA reveals a deeper communal quandary, especially in light of the agency’s inability to assess a human-based intervention combined with